Found 23 matching trials
A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant PHASE2 The researchers are doing this study to compare 2 different GVHD prevention...
Show More Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Learn More & Join Trial
Ruxolitinib in Combination With Autotransplant NA To determine the safety of the approach of giving RUXOLITINIB before and af...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Assess Real-World Patient-Reported Outcomes With Fedratinib for Myelofibrosis Post-Ruxolitinib N/A The purpose of this study is to determine real-world patient-reported outco...
Show More Location
Cardinal Health Specialty Solutions
Learn More & Join Trial
Ruxolitinib With Calcineurin Inhibitor and Methotrexate vs. Calcineurin Inhibitor Plus Methotrexate and Mycophenolate Mofetil as Graft Versus Host Disease Prophylaxis for HLA-haploidentical Hematopoietic Stem Cell Transplantation NA Low Dose Ruxolitinib with Calcineurin Inhibitor and Methotrexate vs. Calcin...
Show More Location
The First Hospital of Zhejiang Medical Colleage Zhejiang University
Learn More & Join Trial
Assess Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profile of Ruxolitinib With Artemether-lumefantrine PHASE1 Phase 1, single -center study in 2 parts. The study designs for each part a...
Show More Location
Nucleus Network Brisbane
Learn More & Join Trial
Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy PHASE3 The primary purpose of this trial is to demonstrate the superiority of MC05...
Show More Location
Centre Hospitalier Universitaire (CHU) Amiens-Picardie - Hopital Sud
Learn More & Join Trial
A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients PHASE1 This is a phase 1, multicenter, open-label study evaluating the safety and ...
Show More Location
Global Oncology, Inc.
Learn More & Join Trial
An Open-Label Study of Ruxolitinib Given With Chemotherapy in Patients With Advanced Solid Tumors PHASE1 This is a study of ruxolitinib in combination with gemcitabine with or with...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms PHASE1 This study is being conducted to evaluate the safety, tolerability, dose-li...
Show More Location
City of Hope Medical Center
Learn More & Join Trial
RVU120 in Patients With Intermediate or High-risk, Primary or Secondary Myelofibrosis PHASE2 The objective of this clinical trial is to evaluate the efficacy (how well ...
Show More Location
Policlinico Sant'Orsola-Malpighi
Learn More & Join Trial